Huidong Liu

Huidong Liu


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
SHSongNan Hao
SongNan Hao
YYYanMei Yang
YanMei Yang
YLYan Liu
Yan Liu
SYShuCai Yang
ShuCai Yang
GWGeng Wang
Geng Wang
HLHuidong Liu
Huidong Liu

22 June 2018 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
JXJian-Bing Xiao
Jian-Bing Xiao
XLXin-Lei Li
Xin-Lei Li
LLLe Liu
Le Liu
GWGeng Wang
Geng Wang
SHSong-Nan Hao
Song-Nan Hao
HLHuidong Liu
Huidong Liu
Semaphorin 5A has been linked to tumor growth, invasion, and metastasis in pancreatic cancer. However, the role of semaphorin 5A in cervical cancer is not known. Our aim is to investigate the prognostic value of semaphorin 5A and its potential role in lymphangiogenesis and invasion in cervical cancer. In this study, pathological features and clinical data of 232 cervical cancer patients were retrospectively reviewed. Semaphorin 5A protein and mRNA expression was detected by immunohistochemistry and quantitative real-time reverse transcription-polymerase chain reaction, respectively. In vitro, we determined the role and mechanistic pathways of semaphorin 5A in tumor progression in cervical carcinoma cell lines. Semaphorin 5A expression was significantly higher in stage IIb tumors than in stage Ia, Ib, and IIa tumors. High semaphorin 5A expression was significantly associated with pelvic lymph node metastasis, lymphovascular permeation, and poor survival. Semaphorin 5A induced lymphangiogenesis through a plexin-B/Met/vascular endothelial growth factor-C pathway. Semaphorin 5A also increased cervical cancer cell invasion by stimulating the expression and activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 via PI3K/AKT and plexin-B3. Our findings indicate that semaphorin 5A may represent a poor prognostic biomarker and anti-metastasis therapeutic target in cervical cancer.

1 June 2005
Verified
Journal Article
Closed access
HLHuidong Liu
Huidong Liu
LZLing-Hui Zhao
Ling-Hui Zhao
YZYa-Fang Zhang
Ya-Fang Zhang
YLYu-Lan Li
Yu-Lan Li
XLXiao-Dong Li
Xiao-Dong Li
CNChun-Sheng Nie
Chun-Sheng Nie